Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health and Human Services
Grant: HHSN272201000052I
U.S. Department of Health and Human Services
Grant: HHSN272200900052C
National Institute of Allergy and Infectious Diseases
Grant: K23-AI-104780
National Institute of Allergy and Infectious Diseases
Grant: UL1TR001082
National Institute of Allergy and Infectious Diseases
Grant: NCRR/NIH 1UL1RR025780
National Institute of Allergy and Infectious Diseases
Grant: UL1TR000075
National Institute of Allergy and Infectious Diseases
Grant: 5R01AI098077
National Institute of Allergy and Infectious Diseases
Grant: N01-AI-90052
National Institute of Allergy and Infectious Diseases
Grant: UL1TR000077-04
NIAID NIH HHS
Grant: UM1 AI109565
NIAID NIH HHS
Grant: R01 AI098077
NCATS NIH HHS
Grant: UL1 TR000154
NCRR NIH HHS
Grant: UL1 RR025780
NCATS NIH HHS
Grant: UL1 TR001105
NCATS NIH HHS
Grant: UL1 TR000040
NCATS NIH HHS
Grant: UL1 TR000150
NIAID NIH HHS
Grant: L40 AI107923
NCATS NIH HHS
Grant: UL1 TR000077
NIAID NIH HHS
Grant: UM2 AI117870
NIAID NIH HHS
Grant: K23 AI104780
NCATS NIH HHS
Grant: UL1 TR000451
Novartis Pharmaceuticals Corporation
GlaxoSmithKline
Mylan
National Institutes of Health
University of Wisconsin-Madison
FWCI
1.69
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals